Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider
06:46pm, Thursday, 11'th Dec 2025
In the most recent trading session, Johnson & Johnson (JNJ) closed at $210.01, indicating a +1.68% shift from the previous trading day.
5 Dividend Powerhouses That Belong in Every Retirement Portfolio Right Now
05:28pm, Wednesday, 10'th Dec 2025
For investors approaching or in retirement, the right stock portfolio balances reliable income, low volatility, and consistent dividend growth.
JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now?
08:35am, Wednesday, 10'th Dec 2025
JNJ and PFE battle patent cliffs and policy headwinds, but rising estimates and stronger 2025 momentum push JNJ ahead in this blue-chip faceoff.
First Look: Fed Cut Looms; SpaceX IPO; J&J Myeloma Data; Google Probe
07:37am, Wednesday, 10'th Dec 2025
Stock News Fed set for a âhawkish cutâ: The Federal Reserve is widely expected to deliver a third 25 bp rate cut amid sharp divisions over inflation vs. job
GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities
09:50pm, Tuesday, 09'th Dec 2025
The US Equity Income Fund underperformed its benchmark, the Russell 1000 Value Index, net of fees during the third quarter. Enterprise software company, Oracle Corporation, was a top contributor to re
5 defensive stocks traders are buying before the Fed rate-cut decision
12:18pm, Tuesday, 09'th Dec 2025
With the Federal Reserve set to announce its final policy decision of 2025 on Wednesday, investors are rotating into defensive positions. More than the rate-cut possibility (which is around 90% as per
1 Major Factor Behind the Healthcare Sector's Recent Surge
10:55am, Tuesday, 09'th Dec 2025
Eli Lilly's GLP-1 drug became the world's best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other companies are soaring on new drugs or the growth of existing ones.
The 5 Best S&P 500 Dividend Aristocrat Stocks to Buy Before 2026
09:18am, Tuesday, 09'th Dec 2025
Investors love S&P 500 dividend stocks, especially those with dependable, high yields, because they provide a substantial passive income stream and offer significant total return potential.
3 Under-the-Radar Dividend Stocks Quietly Beating the Market
07:50am, Tuesday, 09'th Dec 2025
For reasons that seem pretty obvious, dividend investors tend to chase the most familiar names like Pepsi (NYSE:PEP), Johnson and Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG), and they do so for
TECVAYLI® and DARZALEX FASPRO® combination led to a statistically significant progression-free survival and overall survival advantage compared to standard treatment after three years of follow-up C
Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference
04:25pm, Monday, 08'th Dec 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12th, 2026. Management will participate in a Fi
Why 2026 Could Be the Breakout Year for Dividend Growth Investors
01:10pm, Monday, 08'th Dec 2025
Dividend growth investing has always had an appeal to people who are looking to boost their income, find stability in another unstable market, and build long-term wealth. However, 2026 is shaping up t
Can J&J Offset Stelara LOE, MedTech China and Legal Headwinds in 2026?
12:11pm, Monday, 08'th Dec 2025
J&J faces Stelara losses, Medicare shifts, talc suits and China pressure, banking on new products and expects segment growth to stay on track.
Bank of Nova Scotia Raises Stake in Johnson & Johnson $JNJ
03:34am, Monday, 08'th Dec 2025
Bank of Nova Scotia increased its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 29.0% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exch
The Generational Shift I See Now - And My 33 Stocks For What's Coming
07:30am, Sunday, 07'th Dec 2025
I see a generational opportunity in quality stocks, defined by high ROE, stable earnings growth, and low debt. Quality stocks have underperformed AI-driven leaders, creating rare relative value and at
